According to the new market research report "Blood Screening Market by Technology (Nucleic Acid Amplification, (Real Time PCR), ELISA (Chemiluminescence immunoassay), Rapid Test, Western Blot), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital) - Global Forecast to 2025", published by MarketsandMarkets™, the Blood Screening Market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%.
Browse in-depth TOC on "Blood Screening Market"
372 – Tables
31 – Figures
153 – Pages
Request for PDF Brochure:-
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042
The increasing demand for donated blood, the rising
number of blood donations, the growing prevalence of infectious diseases, and
the increasing prevalence of newer pathogens are the key factors driving the
growth of this market.
The reagents & kits segment accounted for the
largest share of the market, by product & service, in 2019
Based on product & service, the Blood Screening
Market is segmented into reagents and kits, instruments, and software and
services. The reagents and kits segment accounted for the largest share of the
market in 2019. The large share of this segment can be attributed to the high
consumption and repeated use of reagents & kits in blood screening
procedures. Also, the accessibility of a wide range of reagents and the need
for reliable, specific, and fast detection of TTIs are driving the growth of
the blood screening reagents & kits market.
Blood banks segment to register the highest growth
rate during the forecast period
Based on end users, the Blood Screening Market is
segmented into blood banks and hospitals. The blood bank segment accounted for
the larger market share in 2019 and is projected to witness a higher growth
rate during the forecast period. This can be attributed to the increasing
demand for donated blood, a growing number of organ transplantation surgeries,
rising awareness regarding the safety of blood, an increasing number of
donations worldwide, and growth in government funding to charitable trusts.
North
America is the largest regional market for blood
screening
Based on region, the market is segmented into North America, Europe,
the Asia Pacific, Latin America,
and the Middle East and Africa.
In 2019, North America accounted
for the largest market share, followed by Europe.
Factors such as the increasing demand for donated blood, the rising number of
blood donations, the growing prevalence of infectious diseases, and the
increasing prevalence of newer pathogens, the presence of high-quality
infrastructure for hospitals and clinical laboratories, and the presence of
major market players in the region are driving the growth of the Blood
Screening Market in North
America.
Get 10% Customization on this Research Report:- https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=267747042
The prominent players operating in the Blood
Screening Market include Grifols (Spain),
F. Hoffmann-La Roche AG (Switzerland),
Abbott Laboratories (US), BioMérieux (France),
Bio-Rad Laboratories (US), Siemens Healthineers (Germany),
Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical
Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy),
GFE (Germany),
Trinity Biotech (Ireland),
Merck Millipore (Germany),
GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra
& Co. Pvt. Ltd (India).
Browse Related Report:
In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology
(Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology,
Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html
Mycoplasma Testing
Market by Product & Service (Assays,
Kits, Reagents), Technique (NAT, ELISA, Staining), Application (Cell Line, End
of Production Testing), End User (Biopharmaceutical, Cell Banks, CROs), Region
- Global Forecast to 2025
https://www.marketsandmarkets.com/Market-Reports/mycoplasma-testing-market-136509856.html
No comments:
Post a Comment